Patent · US Expired

Steroid/thyroid hormone receptor-related protein inappropriately expressed in human hepatocellular carcinoma

US5223606A · kind A · utility

4Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 1987
Grant dateJun 29, 1993
Priority date
Expiry dateDec 17, 2007

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/846
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A previously isolated hepatitis B virus (HBV) integration in a 147 bp cellular DNA fragment linked to hepatocellular carcinoma (HCC) was used as a probe to clone the corresponding complementary DNA from a human liver cDNA library. Nucleotide sequence analysis revealed that the overall structure of the cellular gene, which has been named hap, is similar to that of the DNA-binding hormone receptors. Six out of seven hepatoma and hepatoma-derived cell-lines express a 2.5 kb hap mRNA species which is undetectable in normal adult and fetal livers, but present in all non-hepatic tissues analyzed. Low stringency hybridization experiments revealed the existence of hap related genes in the human genome. The cloned DNA sequence is useful in the preparation of pure hap protein and as a probe in the detection and isolation of complementary DNA and RNA sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.